Literature DB >> 11306444

Quartz exposure of the rat lung leads to a linear dose response in inflammation but not in oxidative DNA damage and mutagenicity.

F Seiler1, B Rehn, S Rehn, M Hermann, J Bruch.   

Abstract

Exposure to quartz and high concentrations of other poorly soluble particles can lead to the development of lung tumors in the rat. The mechanisms involved in particle-induced carcinogenesis seem to include inflammation-associated production of reactive oxygen species (ROS) and DNA damage. ROS induce 8-oxoguanine (8-oxoGua) and a panel of other oxidation products in DNA. In proliferating cells such DNA lesions can lead to various types of mutations, which might be critical for cancer-related genes with respect to tumor formation. Quartz is known to mediate the induction of 8-oxoGua in the nuclear DNA of lung cells when applied to the lung of rats. We have investigated the time- and dose-dependent biologic effects of quartz and, as a control, corundum, on cell proliferation and various pulmonary inflammation and toxicity markers in rat bronchoalveolar lavage fluid (BALF); on the induction of 8-oxoGua in the DNA of rat lung cells; and on the cellular levels of p53 wild-type and p53 mutant (mut) protein. Rats were exposed by intratracheal instillation to various amounts of quartz (0.3, 1.5, or 7.5 mg/rat) or corundum (0.3, 1.5, or 7.5 mg/rat) and measured at Days 7, 21, and 90 after exposure. Corundum had no adverse effects except a slight elevation of 8-oxoGua at a dose of 7.5 mg/rat. However, significant changes in the BALF were detected at all quartz doses. 8-oxoGua was significantly increased only at 1.5 and 7.5 mg quartz/rat. The amount of cells with detectable p53 wild-type protein levels was increased at 1.5 and 7.5 mg quartz/rat at 7 and 21 d. Elevated amounts of cells with enhanced p53 mut protein levels were measured at all time points after instillation of 7.5 mg quartz/rat.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306444     DOI: 10.1165/ajrcmb.24.4.4181

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  6 in total

1.  Impact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammation.

Authors:  Ilse Gosens; Jan Andries Post; Liset J J de la Fonteyne; Eugene H J M Jansen; John W Geus; Flemming R Cassee; Wim H de Jong
Journal:  Part Fibre Toxicol       Date:  2010-12-02       Impact factor: 9.400

2.  The crucial role of particle surface reactivity in respirable quartz-induced reactive oxygen/nitrogen species formation and APE/Ref-1 induction in rat lung.

Authors:  Catrin Albrecht; Ad M Knaapen; Andrea Becker; Doris Höhr; Petra Haberzettl; Frederik J van Schooten; Paul J A Borm; Roel P F Schins
Journal:  Respir Res       Date:  2005-11-02

3.  Translational toxicology in setting occupational exposure limits for dusts and hazard classification - a critical evaluation of a recent approach to translate dust overload findings from rats to humans.

Authors:  Peter Morfeld; Joachim Bruch; Len Levy; Yufanyi Ngiewih; Ishrat Chaudhuri; Henry J Muranko; Ross Myerson; Robert J McCunney
Journal:  Part Fibre Toxicol       Date:  2015-04-23       Impact factor: 9.400

4.  Effects from a 90-day inhalation toxicity study with cerium oxide and barium sulfate nanoparticles in rats.

Authors:  Daniela Schwotzer; Heinrich Ernst; Dirk Schaudien; Heiko Kock; Gerhard Pohlmann; Clemens Dasenbrock; Otto Creutzenberg
Journal:  Part Fibre Toxicol       Date:  2017-07-12       Impact factor: 9.400

5.  Cobalt nanoparticles induce lung injury, DNA damage and mutations in mice.

Authors:  Rong Wan; Yiqun Mo; Zhenyu Zhang; Mizu Jiang; Shichuan Tang; Qunwei Zhang
Journal:  Part Fibre Toxicol       Date:  2017-09-18       Impact factor: 9.400

6.  An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials.

Authors:  Martin Wiemann; Antje Vennemann; Ursula G Sauer; Karin Wiench; Lan Ma-Hock; Robert Landsiedel
Journal:  J Nanobiotechnology       Date:  2016-03-05       Impact factor: 10.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.